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Prolonged and/or irregular breakthrough bleeding is one of the major complications of most progestogenonly contraceptive. In particular, a significant number of women using the subdermal contraceptive implant, Norplant@, is siriously inconvenienced by unwanted alterations in menstrual bleeding pattern. Recently, research into the causes of Progestogen-induced breakthrough bleeding has focused on the role oflocal factors acting within the endometrium. In the absence of good animal models, this work has been carried out almost entirely on endometrial biopsy samples obtained from women using progestogen-only contraceptive methods. In a majority of the patients using Department In a brief analysis of a number of clinical parameters, some significant differences were found between those patients from whom a successful biopsy was obtained, and those from whom no endometrium was collected.
These data are listed in Table 2 and show very significant differences in both bleeding days, and average peripheral estrogen levels between women from whom endometrial tissue was obtained and those from whom lissue was not obtained. Similar analyses for body weight and length of Norplant@ ""porur"
showed no significant differences between the two groups. The finding of significant differences in both bleeding days and average estrogen levels between the groups from which a biopsy was obtained versus those from 0 fi)o3 0.0018
